FULC Fulcrum Therapeutics, Inc.
Nasdaq · SEC CIK 1680581 · EDGAR
- Bought, last 12 months
- $1.49M 2 purchases by 1 insiders
- Sold, last 12 months
- $59.15M 7 sales by 4 insiders
- Filings on record
- 105 since 2021-08-12, latest 2026-07-20 21:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA Capital Healthcare Fund LP | 10% | — | $58.38M |
| TANG KEVIN | 10% | $1.49M | — |
| Gould Robert J | Dir | — | $667.4K |
| Ezekowitz Alan | Dir | — | $65.6K |
| Oltmans Curtis Gale | CLO | — | $44.6K |
Transactions 40
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-07-20 21:10 | 2026-07-16+ | FULC | TANG KEVIN | 10% | P - Purchase | $3.55 | +167.6K | 7.08M | +2% | +$594.7K |
| MI | 2026-07-15 19:50 | 2026-07-13+ | FULC | TANG KEVIN | 10% | P - Purchase | $3.57 | +249.9K | 6.91M | +4% | +$891.1K |
| 2026-06-30 16:30 | 2026-06-26 | FULC | Ezekowitz Alan | Dir | S - Sale | $3.65 | -18.0K | 10.9K | -62% | -$65.6K | |
| A | 2026-02-04 | 2026-01-02 | FULC | Gould Robert J | Dir | S - Sale | $10.87 | -15.0K | 469.9K | -3% | -$163.1K |
| 2026-02-04 | 2026-02-02 | FULC | Gould Robert J | Dir | S - Sale | $10.72 | -15.0K | 454.9K | -3% | -$160.8K | |
| 2026-01-06 | 2026-01-02 | FULC | Gould Robert J | Dir | S - Sale | $11.87 | -15.0K | 469.9K | -3% | -$178.1K | |
| 2025-12-17 | 2025-12-15 | FULC | Oltmans Curtis Gale | CLO | S - Sale | $12.92 | -3,452 | 10.3K | -25% | -$44.6K | |
| MI | 2025-12-10 | 2025-12-08 | FULC | RA Capital Healthcare Fund LP | 10% | S - Sale | $13.98 | -4.18M | 6.15M | -40% | -$58.38M |
| 2025-11-21 | 2025-11-19 | FULC | Gould Robert J | Dir | S - Sale | $11.03 | -15.0K | 484.9K | -3% | -$165.4K | |
| 2025-05-09 | 2025-05-08 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $5.06 | -498 | 14.1K | -3% | -$2,520 | |
| DI | 2024-08-23 | 2024-08-21 | FULC | Shah Rajeev M. | 10% | J - Other | — | -8.50M | 3.11M | -73% | — |
| D | 2024-07-08 | 2024-07-03 | FULC | Sapir Alex | See Remarks, Dir | M - OptEx | $3.27 | +150.0K | 193.4K | +346% | +$490.5K |
| 2024-05-09 | 2024-05-07 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $7.76 | -236 | 11.6K | -2% | -$1,831 | |
| 2024-03-08 | 2024-03-08 | FULC | Tourangeau Greg | VP, Fin | S - Sale | $11.72 | -4,884 | 11.8K | -29% | -$57.2K | |
| 2024-03-05 | 2024-03-04 | FULC | Sapir Alex | See Remarks, Dir | P - Purchase | $11.35 | +43.4K | 43.4K | New | +$492.1K | |
| 2023-05-11 | 2023-05-10 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $3.31 | -210 | 16.0K | -1% | -$695.10 | |
| I | 2023-01-24 | 2023-01-20 | FULC | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $13.00 | +1.92M | 11.61M | +20% | +$25.00M |
| 2023-01-13 | 2023-01-13 | FULC | Gould Robert J | CEO, Interim Pres, Dir | S - Sale | $15.00 | -6,766 | 499.9K | -1% | -$101.5K | |
| MI | 2023-01-06 | 2023-01-04 | FULC | RA Capital Healthcare Fund LP | 10% | P - Purchase | $7.28 | +180.7K | 9.63M | +2% | +$1.32M |
| I | 2022-12-29 | 2022-12-27 | FULC | Kolchinsky Peter | 10% | P - Purchase | $5.99 | +4,089 | 9.51M | +0.0% | +$24.5K |
| I | 2022-12-21 | 2022-12-19 | FULC | Kolchinsky Peter | 10% | P - Purchase | $5.90 | +98.8K | 9.50M | +1% | +$582.8K |
| MI | 2022-12-16 | 2022-12-14+ | FULC | RA CAPITAL MANAGEMENT, L.P. | 10% | P - Purchase | $5.44 | +2.40M | 8.06M | +42% | +$13.08M |
| 2022-12-15 | 2022-12-13 | FULC | TRV GP III, LLC | 10% | J - Other | — | -2.00M | 1.96M | -50% | — | |
| D | 2022-06-08 | 2022-06-07 | FULC | Gould Robert J | Dir | S - Sale+OE | $8.09 | -71.4K | 506.6K | -12% | -$577.9K |
| D | 2022-06-08 | 2022-06-07 | FULC | Gould Robert J | Dir | M - OptEx | $7.84 | +71.4K | 578.1K | +14% | +$560.1K |
| DM | 2022-06-06 | 2022-06-02+ | FULC | Gould Robert J | Dir | S - Sale+OE | $8.00 | -66.6K | 506.6K | -12% | -$532.8K |
| DM | 2022-06-06 | 2022-06-02+ | FULC | Gould Robert J | Dir | M - OptEx | $7.84 | +66.6K | 532.2K | +14% | +$522.3K |
| D | 2022-05-10 | 2022-05-06 | FULC | Tourangeau Greg | Ctrl | A - Grant | $0.00 | +3,250 | 16.2K | +25% | $0 |
| D | 2022-04-11 | 2022-04-07 | FULC | Gould Robert J | Dir | S - Sale+OE | $24.02 | -5,631 | 506.6K | -1% | -$135.3K |
| D | 2022-04-11 | 2022-04-07 | FULC | Gould Robert J | Dir | M - OptEx | $7.84 | +5,631 | 512.3K | +1% | +$44.1K |
| DM | 2022-04-05 | 2022-04-01+ | FULC | Gould Robert J | Dir | M - OptEx | $7.84 | +94.3K | 559.2K | +20% | +$738.9K |
| DM | 2022-04-05 | 2022-04-01+ | FULC | Gould Robert J | Dir | S - Sale+OE | $24.16 | -94.3K | 506.6K | -16% | -$2.28M |
| 2021-11-12 | 2021-11-10 | FULC | STARR KEVIN P | 10% | J - Other | — | -1.00M | 3.96M | -20% | — | |
| I | 2021-11-12 | 2021-11-10 | FULC | LEVIN MARK J | Dir, 10% | J - Other | — | -1.00M | 3.96M | -20% | — |
| I | 2021-09-24 | 2021-09-22 | FULC | LEVIN MARK J | Dir, 10% | J - Other | — | -1.00M | 4.96M | -17% | — |
| 2021-09-24 | 2021-09-22 | FULC | STARR KEVIN P | 10% | J - Other | — | -1.00M | 4.96M | -17% | — | |
| DM | 2021-08-12 | 2021-08-10+ | FULC | Stuart Bryan | See Remarks, Dir | M - OptEx | $7.84 | +60.0K | 32.0K | New | +$470.4K |
| DM | 2021-08-12 | 2021-08-10+ | FULC | Stuart Bryan | See Remarks, Dir | S - Sale+OE | $20.42 | -60.0K | 0 | -100% | -$1.23M |
| DM | 2021-08-12 | 2021-08-10 | FULC | Moxham Christopher | CSO | S - Sale+OE | $17.60 | -51.8K | 0 | -100% | -$911.4K |
| DM | 2021-08-12 | 2021-08-10 | FULC | Moxham Christopher | CSO | M - OptEx | $7.84 | +51.8K | 20.7K | New | +$406.0K |
Purchase Sale Sale after option exercise All abbreviations